Documents
Chiral Separation of Levetiracetam Using the USP Method on the Latest L51 USP Column - Lux Amylose-1 (TN-1185)
In this technical note, we report the enantiomeric separation of Levetiracetam using the approved United States Pharmacopeia method. We perform the chiral analysis on the latest L51 USP column, the polysaccharide-based chiral stationary phase Lux Amylose-1 column, and compare analytical result as well as performance to CHIRALPAK AD-H column.
Chiral Separation of Levetiracetam Using the USP Method on the Latest L51 USP Column - Lux Amylose-1 (TN-1185)
In this technical note, we report the enantiomeric separation of Levetiracetam using the approved United States Pharmacopeia method. We perform the chiral analysis on the latest L51 USP column, the polysaccharide-based chiral stationary phase Lux Amylose-1 column, and compare analytical result as well as performance to CHIRALPAK AD-H column.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Chiral
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
